Streamlining laboratory expenditures through direct to consumer testing and reference prices: first do not harm

نویسندگان
چکیده

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

First do not harm

I would say I am grateful to those authors to refer to my work endorsed by the Wonca International Classification Committee (WICC) and I am pretty proud to contribute to the general reflection about the patient doctor relationship and its consequences for the organization of health care. I have been amazed to read, soon after, two other Indian publications dealing with quaternary prevention in ...

متن کامل

Do Producer Prices Lead Consumer Prices?

From June 1994 to June 1995, producer prices increased rapidly. Excluding food and energy, prices of crude materials and intermediate goods rose at annual rates of 7.2 and 16.7 percent, respectively. At the same time, however, prices of consumer goods and services excluding food and energy increased a more modest 2.9 percent. Many analysts are concerned that recent increases in the prices of cr...

متن کامل

First, do no harm

Conservation agencies charged with care of threatened plant species should be governed by the concepts that conservation actions should do no harm. Adaptive management research progresses in imperfect situations due to incomplete knowledge. Interpreting new experimental or observational evidence for inclusion in conservation plans should first consider the big picture by identifying collateral ...

متن کامل

First, do no harm.

Accessible online at: www.karger.com/onk Fax +49 761 4 52 07 14 [email protected] www.karger.com vational study, Pinder et al. report a 26% increased risk of CHF in older women treated with adjuvant anthracyclines for breast cancer, compared with non-anthracycline regimens [8]. Cardiac troponins are regulatory proteins that control the calcium-mediated interaction of actin and myosin. The t...

متن کامل

First, do no harm.

Early this summer a healthy 62-year-old man with a history of colorectal cancer came to see me for his periodic health examination. In an effort to embrace patient-centred, evidence-informed decision making, much of these visits with healthy men 50 and older in my practice seems to be taken up with discussing the risks and benefits of screening for prostate cancer with a prostate-specific antig...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Annals of Translational Medicine

سال: 2016

ISSN: 2305-5839,2305-5847

DOI: 10.21037/atm.2016.09.41